Spherix’s coverage of emerging neurology indications focuses on evolving markets where a paradigm shift is expected in the coming years.
Benchmarking new brand performance
Aduhelm (Biogen) in Alzheimer's Disease (US)
Prepping for the pipeline
Amyotrophic Lateral Sclerosis (US)
Alzheimer's Disease (US)